Approval · Notice of Compliance 23723 · 2020
ACZONE: Notice of Compliance 23723
Issued June 4, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23723
- Date
- June 4, 2020
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Administrative: Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACZONE | 02281074 | Marketed |
Medicinal ingredients
- DAPSONE 5 PER